e-learning
resources
Virtual 2021
07.09.2021
What's new in respiratory problems in rare and systemic diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical Characteristics of Methotrexate Associated Lymphoproliferative Disorders >Please type your abstract title in Sentence case.
M. Suzuki (Tokyo, Japan), S. Matsubayashi (Tokyo, Japan), K. Sakamoto (Tokyo, Japan), M. Iikura (Tokyo, Japan), S. Izumi (Tokyo, Japan), M. Hojo (Tokyo, Japan), H. Sugiyama (Tokyo, Japan)
Source:
Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Session:
What's new in respiratory problems in rare and systemic diseases
Session type:
E-poster
Number:
3296
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Suzuki (Tokyo, Japan), S. Matsubayashi (Tokyo, Japan), K. Sakamoto (Tokyo, Japan), M. Iikura (Tokyo, Japan), S. Izumi (Tokyo, Japan), M. Hojo (Tokyo, Japan), H. Sugiyama (Tokyo, Japan). Clinical Characteristics of Methotrexate Associated Lymphoproliferative Disorders >Please type your abstract title in Sentence case.. 3296
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Book review - Asthma: Comorbidities, Coexisting Conditions, and Differential Diagnosis
Source: Eur Respir Rev 2014; 23: 538
Year: 2014
Case presentation: Neuromuscular Disorders, a day-to-day challenge
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Problems of Importance in Severe Asthma: A Patient Perspective
Source: International Congress 2019 – Person-centred approaches to COPD and asthma care
Year: 2019
What Can Be Expected From Pathology Assessment? Or: Is Severe Asthma Still an Eosinophilic Disease?
Source: Research Seminar 2007 - Severe Asthma
Year: 2007
Exploration of the Genetic Etiology of Complex Inflammatory Disorders: The Example of Crohn’s Disease
Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases
Year: 2004
Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT)
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Performance of Brief ICF-Sleep Disorders and Obesity Core Set in OSA Patients
Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders
Year: 2020
Introduction to
T
he
E
pidemiology and
N
atural History of Asthma:
O
utcomes and Treatment
R
egimens (TENOR) study
Source: Eur Respir J 2002; 20: Suppl. 38, 426s
Year: 2002
Presentation and clinical evolution of Pulmonary Embolism in patients with Mental Disorders
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019
Pulmonary Circulation: Diseases and their Treatment. 3rd Edition.
Source: Eur Respir Rev 2012; 21: 78
Year: 2012
Book review: Respiratory Care: Principles and Practice, Second Edition
Source: Eur Respir Rev 2015; 24: 373
Year: 2015
Book Review: Scleroderma: From Pathogenesis to Comprehensive Management
Source: Eur Respir Rev 2012 21: 371
Year: 2012
A Study on Various Types of Presentations of Paediatric Tuberculosis and Response to Fixed Dose Combination (FDC).
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
Postinfectious Bronchiolitis Obliterans in Children - Diagnostic Workup and Therapeutic Options - A Workshop Report
Source: Virtual Congress 2020 - Pre-reading material
Year: 2020
Does Speech Disorder (Aphasia) Affect Respiratory Muscle Strength in Stroke?
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017
Menstrual Disorders in Non-genital Tuberculosis – an Ignored Entity
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
Severe Asthma: A Clinically Heterogeneous Entity
Source: Research Seminar 2007 - Severe Asthma
Year: 2007
Book Review: Sleep Disordered Breathing in Children: A Comprehensive Clinical Guide to Evaluation and Treatment
Source: Eur Respir Rev 2013; 22: 420
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept